Cornerstone Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.86M | Buy |
22,273
+191
| +0.9% | +$22.4K | 0.12% | 161 |
|
|
2026
Q1 | $2.66M | Sell |
22,082
-534
| -2% | -$61.6K | 0.13% | 155 |
|
|
2025
Q4 | $2.38M | Sell |
22,616
-94
| -0.4% | -$8.82K | 0.12% | 162 |
|
|
2025
Q3 | $1.91M | Buy |
22,710
+133
| +0.6% | +$11K | 0.11% | 180 |
|
|
2025
Q2 | $1.79M | Buy |
22,577
+840
| +4% | +$66.8K | 0.11% | 166 |
|
|
2025
Q1 | $1.95M | Sell |
21,737
-365
| -2% | -$34.1K | 0.13% | 151 |
|
|
2024
Q4 | $2.2M | Buy |
22,102
+821
| +4% | +$84.6K | 0.15% | 139 |
|
|
2024
Q3 | $2.42M | Buy |
21,281
+452
| +2% | +$53.7K | 0.17% | 122 |
|
|
2024
Q2 | $2.58M | Sell |
20,829
-65
| -0.3% | -$8.37K | 0.2% | 108 |
|
|
2024
Q1 | $2.76M | Sell |
20,894
-117
| -0.6% | -$14.4K | 0.22% | 100 |
|
|
2023
Q4 | $2.29M | Buy |
21,011
+19
| +0.1% | +$1.97K | 0.2% | 113 |
|
|
2023
Q3 | $2.16M | Buy |
20,992
+1,377
| +7% | +$148K | 0.2% | 111 |
|
|
2023
Q2 | $2.26M | Sell |
19,615
-105
| -0.5% | -$11.9K | 0.2% | 114 |
|
|
2023
Q1 | $2.1M | Buy |
+19,720
| New | +$2.13M | 0.21% | 107 |
|
|
2022
Q3 | $1.72M | Buy |
19,992
+556
| +3% | +$49.6K | 0.19% | 110 |
|
|
2022
Q2 | $1.77M | Buy |
19,436
+442
| +2% | +$39.2K | 0.2% | 110 |
|
|
2022
Q1 | $1.56M | Buy |
18,994
+1,299
| +7% | +$102K | 0.15% | 132 |
|
|
2021
Q4 | $1.36M | Buy |
17,695
+1,556
| +10% | +$124K | 0.13% | 150 |
|
|
2021
Q3 | $1.21M | Sell |
16,139
-128
| -0.8% | -$9.73K | 0.13% | 158 |
|
|
2021
Q2 | $1.26M | Buy |
16,267
+1,100
| +7% | +$81.8K | 0.13% | 153 |
|
|
2021
Q1 | $1.12M | Buy |
15,167
+558
| +4% | +$41.2K | 0.13% | 159 |
|
|
2020
Q4 | $1.14M | Buy |
14,609
+4,070
| +39% | +$311K | 0.14% | 139 |
|
|
2020
Q3 | $834K | Buy |
10,539
+440
| +4% | +$34.5K | 0.12% | 160 |
|
|
2020
Q2 | $745K | Buy |
10,099
+1,060
| +12% | +$79.8K | 0.12% | 168 |
|
|
2020
Q1 | $664K | Buy |
9,039
+782
| +9% | +$61.5K | 0.13% | 163 |
|
|
2019
Q4 | $717K | Buy |
8,257
+768
| +10% | +$63.1K | 0.12% | 166 |
|
|
2019
Q3 | $602K | Sell |
7,489
-1,193
| -14% | -$95.6K | 0.11% | 183 |
|
|
2019
Q2 | $691K | Buy |
8,682
+2,046
| +31% | +$157K | 0.12% | 169 |
|
|
2019
Q1 | $1.1M | Sell |
6,636
-144
| -2% | -$10.8K | 0.13% | 175 |
|
|
2018
Q4 | $489K | Sell |
6,780
-584,866
| -99% | -$41.3M | 0.1% | 197 |
|
|
2018
Q3 | $8.78M | Buy |
591,646
+225,566
| +62% | +$14.4M | 0.11% | 197 |
|
|
2018
Q2 | $5.78M | Buy |
366,080
+359,420
| +5,397% | +$20.3M | 0.07% | 288 |
|
|
2018
Q1 | $340K | Sell |
6,660
-278
| -4% | -$15K | 0.06% | 277 |
|
|
2017
Q4 | $372K | Sell |
6,938
-2,260
| -25% | -$125K | 0.07% | 269 |
|
|
2017
Q3 | $570K | Buy |
9,198
+399
| +5% | +$24.2K | 0.12% | 176 |
|
|
2017
Q2 | $530K | Buy |
8,799
+460
| +6% | +$28K | 0.12% | 170 |
|
|
2017
Q1 | $510K | Buy |
8,339
+289
| +4% | +$17.5K | 0.13% | 166 |
|
|
2016
Q4 | $463K | Buy |
8,050
+164
| +2% | +$9.6K | 0.15% | 141 |
|
|
2016
Q3 | $469K | Buy |
+7,886
| New | +$461K | 0.17% | 123 |
|
Other funds holding MRK
LMFP
ATO
AAMU
Cornerstone Wealth Management's MRK Position: Q2 2026 in Review
Cornerstone Wealth Management increased its Merck (MRK) stake by 0.86% in Q2 2026, buying an estimated $22.4K and bringing the position to 22,273 shares worth $2.86M. The position accounts for 0.12% of the portfolio, ranked #161.
Cornerstone Wealth Management first reported a position in MRK in Q3 2016 and has held it in 39 quarters since. The position peaked at $8.78M in Q3 2018. 1,109 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cornerstone Wealth Management held 22,273 shares of Merck worth $2.86M as of Q2 2026.
- Cornerstone Wealth Management bought 191 Merck shares in Q2 2026, an estimated $22.4K.
- Merck made up 0.12% of Cornerstone Wealth Management's portfolio in Q2 2026, its #161 holding.
- Cornerstone Wealth Management first reported a position in Merck in Q3 2016 and has held it in 39 quarters since.
- Cornerstone Wealth Management's Merck position peaked at $8.78M in Q3 2018.
- 1,109 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.